NanoSomiX, Inc.
PrivateTotal Funding Raised
$2M
Company Overview
NanoSomiX, Inc. is a biotechnology company that develops non-invasive blood-based diagnostic assays using brain-derived exosomes to detect and monitor neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
brain-derived exosomesBDEliquid biopsyneurological diagnosticsblood-based assaysCLIA laboratorybiomarker discoveryAlzheimer's diagnosticsexosome isolationneurodegenerative disease researchcontract research organizationCROnon-invasive testingimmunoassayELISA
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoSomiX, Inc. Comparables
Compare NanoSomiX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroDex | 91% | |
| C2N Diagnostics | 83% | |
| FYR Diagnostics | 82% | |
NanoSomiX, Inc. Funding Rounds
Historical fundraising activity
NanoSomiX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Friends & Family Capital | Angel |
NanoSomiX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoSomiX, Inc.'s valuation, stock price, and market status.
See something wrong or outdated?